NCT00919490View on ClinicalTrials.gov

A Study of Single Dose of ABT-333 in Healthy Male Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

August 31, 2009

Conditions
HCV Infections
Interventions
DRUG

ABT-333

Tablet, see arms for interventional description

DRUG

Placebo

Tablet, see arms for interventional description.

Trial Locations (1)

890-0081

Site Reference ID/Investigator# 19102, Kagoshima

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
collaborator

Abbott Japan Co.,Ltd

INDUSTRY

lead

Abbott

INDUSTRY